In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a

Subeer K Wadia1, Mark Belkin2, Kelsey S Chow3

  • 1a Department of Internal Medicine , Ronald Reagan UCLA Medical Center , Los Angeles , CA , USA.

Hospital Practice (1995)
|January 18, 2017
PubMed

Insights

High-intensity statin use in hospitalized high-risk cardiovascular patients is low and varies by medical specialty. Cardiology specialists prescribed high-intensity statins most frequently, highlighting opportunities for quality improvement interventions.

Area of Science:

  • Cardiology
  • Clinical Pharmacy
  • Healthcare Quality Improvement

Background:

  • Clinician adherence to 2013 cholesterol-lowering guidelines is inconsistent.
  • Understanding statin prescribing patterns among specialists treating high-risk cardiovascular patients is crucial.

Purpose of the Study:

  • To examine and compare statin prescribing patterns across different medical specialties.
  • To evaluate the utilization of high-intensity statins in high-risk cardiovascular patients post-guideline release.

Main Methods:

  • Retrospective chart review of 632 adult patients across Cardiology, CV Surgery, Neurology, and Internal Medicine.
  • Analysis of high-intensity statin (atorvastatin 40-80mg, rosuvastatin 20-40mg) prescribing at 6 and 18 months post-2013 guidelines.
  • Inclusion criteria: acute coronary syndrome, post-cardiac surgery, carotid procedures, stroke, TIA, or high-risk chest pain.

Main Results:

  • Overall high-intensity statin discharge rates were: Cardiology (80%-85%), CV Surgery (52%-65%), Neurology (59%-66%), and Internal Medicine (45%-48%).
  • Cardiology demonstrated significantly higher high-intensity statin use compared to other specialties (p < 0.001).
  • Cardiology, CV Surgery, and Neurology showed significant increases in high-intensity statin use from admission to discharge.

Conclusions:

  • High-intensity statin therapy is underutilized in hospitalized high-risk cardiovascular patients.
  • Significant variations in statin prescribing exist among different medical specialties.
  • Findings support the development of quality improvement interventions to enhance statin utilization in this population.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
361